✣OncoGonFROM DISCOVERY TO IMPACT
HomeAssetsTriage & Prioritisation
3D Tumour IntelligenceExperimentsImagingSegmentation & QCResponse AnalysisAI Analysis (OSIEL)
Qualified AssetsIndustry & Data RoomCollaborationReports & Insights
Admin
Home3D Tumour IntelligenceBC-001
Loading study workspace…
3D Tumour Intelligence

BC-001

Response AnalysisRESEARCH MODE

Breast Cancer Spheroid Response Study

AssetOGC-2401CancerBreast CancerSubtypeTNBC, HER2-Model3D Tumour SpheroidLead ScientistDr. S. Mokoena
Review DiscussionAsk OSIEL About This Study
Loading response visualisations…

Study Context

Current scientific record

StageResponse Analysis
QCPassed
ProtocolOG-PROT-3D-021
Images126
Last Updated2026-10-03

Current Attention

Research review queue

Response Analysis review pendingPassed QC status requires confirmation
Research data · human review required.
Response values

Treatment Response

Drug B · Day 7 · All replicates

Viability18%
Tumour Size Change-71%
Relative Volume0.29
Growth Rate-0.14/day
Confidence0.92
Response ClassStrong Response

Quantitative results for interface validation. No scientific calculation is performed.

Illustrative 3D Visualisation

Stylised tumour response · not imaging-derived geometry

Drug B · Day 7
Illustrative visualisation

Growth / Response Over Time

Relative spheroid volume

Treatment Comparison

Day 7 viability and response class

Control96% viabilityGrowth
Drug A62% viabilityPartial Response
Drug B18% viabilityStrong Response

Replicate Variability

Drug B · viability by replicate

Replicate R3 requires QC confirmation before final interpretation.

Analysis Context

Methods and governance

Image-derived metrics are illustrative and require scientist review.

Response labels require scientific review, not a validated classification.

Protocol: OG-PROT-3D-021 · Result version: v1.2